is tirzepatide im or subq Injection Depth Guide: Subcutaneous vs Intramuscular IM vs. Subcutaneous Injections: Key

Tirzepatide is an FDA-approved prescription medication marketed as Mounjaro for type 2 diabetes mellitus and Zepbound for chronic weight management in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity

Never put loose needles in household trash or recycling

New phase 2 data demonstrate potential benefit of nipocalimab for pregnant individuals at high risk of early-onset severe hemolytic disease of the fetus and newborn (HDFN)

Compounded Tirzepatide: Access and Affordability Zepbound, approved by the FDA in 2023, remains a brand-name injectable medication typically priced between $900 and $1,300 per month through retail pharmacies